MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Digital Health / Diabetes: Do smartphones fit the bill for the next mobile artificial pancreas? | MassDevice.com On Call

Diabetes: Do smartphones fit the bill for the next mobile artificial pancreas? | MassDevice.com On Call

August 16, 2013 By Sony Salzman Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Smartphones are capable of meeting all the criteria for an artificial pancreas by providing close-loop, outpatient control of glucose levels for diabetics, according to a new study published by the American Diabetes Assn.

Using modified Android phones, researchers proved that it is possible to make an artificial pancreas fully mobile. They hope to replace the current standard, which is a laptop connected to to the patient’s glucose monitor and insulin pump, according to MobiHealthNews.

The artificial pancreas has been called the “holy grail” of the medical device industry, seamlessly providing diabetic patients with blood glucose monitoring and insulin dosing, but no such devices have made it to the U.S. market. That’s not for lack of trying, however.

Companies like Medtronic (NYSE:MDT) are slowly progressing with its research and development, with Medtronic in particular recently touting positive outcomes for its MiniMed mechanical insulin pump system. Canadian researchers have been comparing their dual-hormone artificial pancreas to conventional diabetes management with positive results.

Many companies and research groups have their eye on that "holy grail," and future iterations of the devices may be able to rely on the smartphones everyone already has in their pockets to manage the system.

 Black box warnings do little to slow dialysis drug use
Despite an FDA "black box" warning on ESA dialysis drugs, which can increase risk of heart attack and stroke, a new study finds the real reason the use of these drugs has dropped is because of a change in Medicare payments. Researchers concluded that ESA-use has been slowly dropping since a 2011 Medicare rule that removed financial incentives for big doses. There was no similar drop in ESA prescriptions following the black box labeling.
Read more

 New CT scan cuts radiation exposure by 31%, study says
Although CT scans are often necessary to map heart and other organ problems, they expose patients to potentially unsafe radiation. Researchers say that hospitals that adopt new CT hardware and software that will cut a patient’s radiation exposure by 31% without sacrificing image quality. Michigan researchers measured radiation doses of almost 12,000 patients, scanned both with the old technology and the new, at 1-year intervals. The 1st scan exposed patients to an average radiation dose of 9.5 mSV, and the 2nd an average of 6.6 mSV.
Read more

 Low-income countries still have low cervical cancer screening rates
Cervical cancer is an easily detected and highly preventable disease, yet screening rates in low- and middle-income countries are still far below higher-income countries. Approximately 53 out of 100,000 women in sub-Saharan Africa develop cervical cancer, compared to 7 out of 100,000 women in Western countries, a study said. Lead author Ruby Singhrao outlined 4 main reasons cervical cancer screenings need to be emphasized in the 2015 Millennium Development Goals.
Read more

 FDA hands Harvard $5.6M to develop its organ-on-a-chip technology
Harvard’s Wyss Institute just landed a $5.6 million contract from the FDA to continue developing its organ-on-a-chip technology, a promising new breakthrough that mimics the functions of a human organ to eliminate risks of human testing. The contract asks Wyss researchers to look into treatments for radiation sickness. The researchers are developing chip versions of the human lung, gut and bone marrow to subject them to radiation damage and evaluate possible treatments.
Read more

Filed Under: Digital Health, News Well, Oncology Tagged With: American Diabetes Assn., Dialysis, Insulin Management, On Call

In case you missed it

  • Employees say Intuitive Surgical, J&J, Stryker best places to work in 2020
  • Eitan Group signs service agreement with Integrated Medical Systems
  • Beta Bionics’ bionic pancreas wins breakthrough status from FDA
  • Sanofi backs away from diabetes partnership with Verily
  • FDA clears Cochlear piezoelectric hearing implant
  • Biolase lands 510(k) for dental hygiene laser
  • Mayo Clinic, W.L. Gore team up on stem cell therapy treatments
  • ViewRay issues urgent field safety notice for MRIdian System Treatment Planning and Delivery System
  • Barry out as InspireMD CEO
  • Report: EtO blood levels higher in Illinois neighbors of Medline sterilization plant
  • FDA clears augmented glenoids for Shoulder Innovations system
  • McKesson names new chief information and technology officer
  • Imperative Care raises $85m
  • CMR Surgical appoints new CEO
  • Peregrine Ventures raises $115m
  • Roche wins CE Mark for blood glucose reading smartphone app
  • Cantel Medical beats The Street in Q1 results

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS